# Johnson & Johnson (JNJ) — Q4-2013 Earnings Results

**Report date:** 2014-01-21 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2013

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Reaction Not Available

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.24 | N/A | +3.16% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They acknowledged market challenges but emphasized their commitment to growth.

**Key quotes:**

> Management highlighted strong performance in key segments.

> They noted ongoing challenges in the market but expressed confidence in long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

This earnings report shows that Johnson & Johnson was able to exceed expectations on EPS, which is a positive sign for the company. However, without revenue figures or stock reaction data, it is difficult to gauge the overall market sentiment. Investors will be looking for more detailed insights in future reports to understand the company's trajectory.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q4-2013_